#biotechnologycompany — Public Fediverse posts

https://www.europesays.com/unitedstates/62928/ What Is Warhound, the War Dog Startup That Just Emerged From Stealth? #AndurilCofounder #BenLamm #BiotechnologyCompany #contribution #dog #HighPerformanceMilitaryDog #man #mission #NewStartup #PalmerLuckey #release #SequoiaCapital #Startups #US #VentureCapital #VentureCapital&Startups #WarDogStartup #Warhound

https://www.europesays.com/britain/133310/ Eccogene Receives $50 Million Milestone Payment from AstraZeneca Following Initiation of Global Phase 3 Program for Elecoglipron (AZD5004/ECC5004) #AmericanDiabetesAssociation #AstraZeneca #BiotechnologyCompany #ClinicalProgram #EjectionFraction #GlobalPhase #InflammatoryDisorders #MilestonePayment #PhaseIIITrials #ReceptorAgonist #Type2Diabetes

https://www.europesays.com/ch/134746/ BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset #BiotechnologyCompany #BoomrayPharmaceuticalsCo #DevelopmentCapabilities #GlobalExpertise #Ltd #Novartis #NovartisPharmaAG #RLT

CoreFX Expands Global Reach with New European Innovation Headquarters in Ireland, Supported by Enterprise Ireland

The new European headquarters will complement CoreFX’s established U.S. operations, acce…
#Europe #EU #biotechnologycompany #commercialexpansion #commercialgrowth #CoreFX #DenisNeville #EnterpriseIreland #European #Europeanheadquarters #foodscience #Ireland #researchcollaboration #scientificdevelopment #scientificinnovation #TeagascMoorepark
https://www.europesays.com/europe/139021/

4DMT Announces New Employment Inducement Grants

4D Molecular Therapeutics, Inc. EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Jobs #biotechnologycompany #Business #MolecularTherapeutics #nasdaq #productcandidate #restrictedstockunits #TheCompany #unprecedentedbenefits
https://www.newsbeep.com/us/844513/

https://www.europesays.com/ch/111297/ Genprex Shares Rise After Collaboration With Roche Diagnostics #AssayValidation #BiotechnologyCompany #ClinicalResearch #GenprexInc #MedicalResearch #NonSmallCellLungCancer #PatientSelection #patients #preclinical #Roche #RocheDiagnostics

Scribe Therapeutics Files $107.2 Million IPO as Sanofi Backs Share Purchase

This article first appeared on GuruFocus. Scribe Therapeutics, a clinical-stage developer of gene therapies for heart disease, is…
#France #FR #Europe #EU #Sanofi #atheroscleroticcardiovasculardisease #biotechnologycompany #genetherapies #NasdaqGlobalMarket #Scribe #U.S.SecuritiesandExchangeCommission
https://www.europesays.com/france/56238/

Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom

More than ten countries and more than twenty sites are now participating in the Company’s global pi…
#UnitedKingdom #UK #Europe #EU #biotechnologycompany #FALCON-HD #GreatBritain #huntington #Huntington'sdisease #Inc. #noveltherapies #pivotaltrial #SkyhawkTherapeutics #UnitedStates
https://www.europesays.com/3129600/

https://www.europesays.com/3129600/ Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom #BiotechnologyCompany #FALCONHD #GreatBritain #huntington #Huntington'sDisease #Inc #NovelTherapies #PivotalTrial #SkyhawkTherapeutics #UnitedKingdom #UnitedStates

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

Engitix Therapeutics Collaboration leverages Engitix’s human ECM Platform to identify high-confidence targets for liver fibrosis regression LONDON, June…
#EuropeSays #Britain #Europe #EU #GSK #biotechnologycompany #developmentcapabilities #diseasemodels #ECM #ECMPlatform #EngitixLtd. #GiuseppeMazza #liverdisease #liverfibrosis #therapeutictargets
https://www.europesays.com/britain/81848/

https://www.europesays.com/britain/81848/ Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression #BiotechnologyCompany #DevelopmentCapabilities #DiseaseModels #ECM #ECMPlatform #EngitixLtd #GiuseppeMazza #GSK #LiverDisease #LiverFibrosis #TherapeuticTargets

https://www.europesays.com/britain/58531/ Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression #BiotechnologyCompany #DevelopmentCapabilities #DiseaseModels #ECM #ECMPlatform #EngitixLtd #GiuseppeMazza #GSK #LiverDisease #LiverFibrosis #TherapeuticTargets

https://www.europesays.com/ch/68456/ Alps Group gets Nasdaq minimum bid-price notice | ALPS SEC Filing #$100BidRule #Alps #AlpsGroup #BiotechnologyCompany #DelistingRisk #ForeignPrivateIssuer #ListingCompliance #NasdaqMinimumBidPrice

https://www.europesays.com/ch/65262/ Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management #BiotechnologyCompany #ClinicalTrials #CompanyAnnouncement #OverweightAndObesity #Roche #WeightManagement #ZealandPharma

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Cogent Biosciences, Inc. Pivotal data from APEX trial in Advanced Systemic Mastocytosis accepted for oral presentation; Cogent’s third…
#Europe #EU #biotechnologycompany #CogentBiosciences #European #EuropeanHematologyAssociation #Inc. #posterpresentation #SystemicMastocytosis
https://www.europesays.com/europe/39629/

https://www.europesays.com/ch/59188/ Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management #BiotechnologyCompany #ClinicalTrials #CompanyAnnouncement #OverweightAndObesity #Roche #WeightManagement #ZealandPharma

GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer

Collaboration builds clinical foundation…
#Japan #JP #Hokkaido #biotechnologycompany #clinicaldevelopment #clinicalstage #gastriccancer #GlycoNex #HokkaidoNews #hokkaidouniversity #Inc. #news #treatmentoption #treatmentoptions #北海道
https://www.alojapan.com/1418105/glyconex-and-hokkaido-university-hospital-launch-study-to-advance-glycan-directed-adc-development-in-gastric-cancer-2/

https://www.alojapan.com/1418105/glyconex-and-hokkaido-university-hospital-launch-study-to-advance-glycan-directed-adc-development-in-gastric-cancer-2/ GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer #BiotechnologyCompany #ClinicalDevelopment #ClinicalStage #GastricCancer #GlycoNex #Hokkaido #HokkaidoNews #HokkaidoUniversity #Inc. #Japan #news #TreatmentOption #TreatmentOptions #北海道 Collaboration builds clinical foundation for GNX1021, a first-in-class glycan-directed ADC being developed for gastric cancer patients  NEW TAIP

Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation (NSF) for Research on Scalability of Exosome-based Therapeutics for Genetic Disease

Funding enables Neucore to pursue manufacturing efficiencies that will help expand the reach of non-viral genetic…
#NewsBeep #News #Genetics #biotechnologycompany #CA #Canada #Columbus #geneticdisorders #geneticmedicine #geneticmutations #NationalScienceFoundation #Ohio #OhioStateUniversity #Science
https://www.newsbeep.com/ca/53274/